Skip Navigation


International Immunology Advance Access originally published online on April 29, 2008
International Immunology 2008 20(6):791-800; doi:10.1093/intimm/dxn037
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
20/6/791    most recent
dxn037v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in Int. Immunol.
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (17)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Kondo, Y.
Right arrow Articles by Nakanishi, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kondo, Y.
Right arrow Articles by Nakanishi, K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


© The Japanese Society for Immunology. 2008. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org

Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system

Yuichi Kondo1,2,*, Tomohiro Yoshimoto1,3,*, Koubun Yasuda1,3, Shizue Futatsugi-Yumikura1,3, Mai Morimoto1,4, Nobuki Hayashi1,3, Tomoaki Hoshino5, Jiro Fujimoto2 and Kenji Nakanishi1,3

1 Department of Immunology and Medical Zoology
2 Department of Surgery, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya, Hyogo 663-8501, Japan
3 Collaborative Development of Innovation Seeds, Japan Science and Technology Corporation, Saitama 332-0012, Japan
4 Department of Internal Medicine, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya, Hyogo 663-8501, Japan
5 Division of Respirology, Neurology and Rheumatology, Department of Medicine, Kurume University School of Medicine, Kurume, Fukuoka 830-0011, Japan

Correspondence to: K. Nakanishi; E-mail: nakaken{at}hyo-med.ac.jp

Systemic administration of IL-18 induces polyclonal IgE responses by causing NKT cells to express CD40 ligand and to produce IL-4. Administration of IL-33 also induces IgE response, although the mechanism underlying IgE response is unclear. Here, we compared the effects of IL-18 and IL-33 on bone marrow-derived mast cells and basophils as well as non-polarized and Th2-polarized CD4+ T cells in vitro. Basophils, comprising IL-18R{alpha}+ cells (14.2%) and IL-33R{alpha}+ cells (34.6%), and mast cells, comprising IL-18R{alpha}+ cells (2.0%) and IL-33R{alpha}+ cells (95.6%), produce IL-4, IL-6, IL-13, granulocyte macrophage colony-stimulating factor (GM-CSF) and chemokines (RANTES, MIP-1{alpha}, MIP-1β and MCP-1), upon stimulation with IL-18 and/or IL-33 in the presence of IL-3. Only basophils strongly produce IL-4. Furthermore, compared with mast cells, basophils produce larger amounts of the above cytokines and chemokines in response to IL-33. Level of IL-33Rβ-mRNA expression in basophils is higher than that in mast cells. Effect of IL-33 is dependent on ST2 binding, and its signal is transduced via MyD88 in vitro. We also found that IL-2 plus IL-18 or IL-33 alone stimulates non-polarized or Th2-polarized CD4+ T cells to produce IL-4 and IL-13 or IL-5 and IL-13, respectively. We finally showed that administration of IL-33 into mice ST2/MyD88 dependently induces airway hyperresponsiveness (AHR) and goblet cell hyperplasia by induction of IL-4, IL-5 and IL-13 in the lungs. Furthermore, same treatment of RAG-2–/– mice, lacking T and B cells, more strikingly induced AHR with marked goblet cell hyperplasia and eosinophilic infiltration in the lungs. Thus, IL-33 induces asthma-like symptom entirely independent of acquired immune system.

Keywords: basophils, IL-33, innate immunity, ST2, Th2 cytokines


* These authors contributed equally to this study.

Transmitting editor: T. Hamaoka

Received 6 February 2008, accepted 26 March 2008.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in Int. Immunol.:

IN THIS ISSUE

Int. Immunol. 2008 20: NP. [Extract] [Full Text]  



This article has been cited by other articles:


Home page
J. Immunol.Home page
M. Kurowska-Stolarska, B. Stolarski, P. Kewin, G. Murphy, C. J. Corrigan, S. Ying, N. Pitman, A. Mirchandani, B. Rana, N. van Rooijen, et al.
IL-33 Amplifies the Polarization of Alternatively Activated Macrophages That Contribute to Airway Inflammation
J. Immunol., November 15, 2009; 183(10): 6469 - 6477.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
E. F. Knol and B. F. Gibbs
Editorial: Basophil survival and immunomodulatory function are uniquely regulated by a novel MyD88-dependent pathway
J. Leukoc. Biol., October 1, 2009; 86(4): 753 - 755.
[Full Text] [PDF]


Home page
J. Immunol.Home page
E. Schneider, A.-F. Petit-Bertron, R. Bricard, M. Levasseur, A. Ramadan, J.-P. Girard, A. Herbelin, and M. Dy
IL-33 Activates Unprimed Murine Basophils Directly In Vitro and Induces Their In Vivo Expansion Indirectly by Promoting Hematopoietic Growth Factor Production
J. Immunol., September 15, 2009; 183(6): 3591 - 3597.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. Cayrol and J.-P. Girard
The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1
PNAS, June 2, 2009; 106(22): 9021 - 9026.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
J. Kearley, K. F. Buckland, S. A. Mathie, and C. M. Lloyd
Resolution of Allergic Inflammation and Airway Hyperreactivity Is Dependent upon Disruption of the T1/ST2-IL-33 Pathway
Am. J. Respir. Crit. Care Med., May 1, 2009; 179(9): 772 - 781.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Pecaric-Petkovic, S. A. Didichenko, S. Kaempfer, N. Spiegl, and C. A. Dahinden
Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33
Blood, February 12, 2009; 113(7): 1526 - 1534.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
Z. Wiener, P. Pocza, M. Racz, G. Nagy, G. Tolgyesi, V. Molnar, J. Jaeger, E. Buzas, E. Gorbe, Z. Papp, et al.
IL-18 induces a marked gene expression profile change and increased Ccl1 (I-309) production in mouse mucosal mast cell homologs
Int. Immunol., December 1, 2008; 20(12): 1565 - 1573.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Kurowska-Stolarska, P. Kewin, G. Murphy, R. C. Russo, B. Stolarski, C. C. Garcia, M. Komai-Koma, N. Pitman, Y. Li, A. N. J. McKenzie, et al.
IL-33 Induces Antigen-Specific IL-5+ T Cells and Promotes Allergic-Induced Airway Inflammation Independent of IL-4
J. Immunol., October 1, 2008; 181(7): 4780 - 4790.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.